Same Indication

Buprenorphine vs Vipivotide Tetraxetan Lutetium

Buprenorphine vs Vipivotide Tetraxetan Lutetium: Overview

This comparison examines the pharmacological differences between Buprenorphine and Vipivotide Tetraxetan Lutetium.

Mechanism of Action

Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

Pharmacokinetics

Half-life: Buprenorphine β€” 24-42 hours.

Chemical Properties

Molecular Formula: Buprenorphine β€” C29H41NO4.

Molecular Weight: Buprenorphine β€” 467.6430 g/mol.

Type: Buprenorphine β€” Small molecule; Vipivotide Tetraxetan Lutetium β€” Protein.